Coppell Advisory Solutions’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-963
Closed -$20.4K 567
2024
Q4
$20.4K Buy
963
+264
+38% +$6.42K ﹤0.01% 884
2024
Q3
$20.8K Buy
+699
New +$17.4K ﹤0.01% 863

Other funds holding CDNA

Coppell Advisory Solutions's CDNA Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of CareDx (CDNA) in Q1 2025, closing a stake of 963 shares — an estimated $20.4K sold.

Coppell Advisory Solutions first reported a position in CDNA in Q3 2024 and held it in 2 quarters. The position peaked at $20.8K in Q3 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 963 CareDx shares in Q1 2025, an estimated $20.4K.
  • Coppell Advisory Solutions first reported a position in CareDx in Q3 2024 and held it in 2 quarters.
  • Coppell Advisory Solutions's CareDx position peaked at $20.8K in Q3 2024.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.